Cannabis (Cannabis sativa)
What Is Cannabis?
Cannabis is listed botanically as Cannabis sativa, a plant of the Cannabaceae family, native to Central and South Asia. The material in circulation is flower, leaf, resin (trichomes) — leafy growth taken above ground. Most people search for it simply as Cannabis; suppliers, pharmacopoeias and interaction databases list it as Cannabis sativa, and matching the two is the first step in identifying what is actually in a product. Its character is described as earthy, pine, skunky, diesel, citrus-terpene, which is often how the raw material is checked for quality.
Use of Cannabis predates its chemical analysis by a long way: earlier records describe it by season, preparation and the part gathered rather than by any constituent, and that practical knowledge is what later study was measured against. Beyond its practical use it carries cultural associations — ancient sacramental plant of introspection, healing, and altered awareness.
Today most searches for Cannabis come from people reading about grounding, bloating, nausea and detox, or checking how it sits alongside a medication they already take. The use most often documented in the literature is THC:CBD combinations reduce chronic neuropathic pain and chemotherapy-induced nausea, followed by epidiolex (purified CBD) is FDA-approved for certain seizure disorders.
How Does Cannabis Work?
Cannabis works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in flower, leaf, resin (trichomes) rather than by one marker molecule.
Before its chemistry was known, Cannabis was judged by what it did in the cup: how strongly it brewed, how it tasted, and how little or much was needed. Those notes are why particular preparations survived and others did not.
The research base is developing: there are human trials, though sample sizes and designs vary, and this profile cites 3 sources. Reported findings centre on cannabis contains >100 cannabinoids (THC, CBD, CBG, CBN) and terpenoids (myrcene, limonene, pinene, caryophyllene). Where research exists, it examines THC:CBD combinations reduce chronic neuropathic pain and chemotherapy-induced nausea, epidiolex (purified CBD) is FDA-approved for certain seizure disorders and sativex (nabiximols) approved in multiple countries for MS spasticity. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into fixed oil and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
Cannabis is studied as a whole preparation because isolating one fraction tends to behave differently from the material it was taken out of — a recurring finding across the plant-chemistry literature.
Because these constituents are processed by the same pathways that handle many medicines, Cannabis is documented as interacting with sedatives / cns depressants, anticoagulants and antiepileptics. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Cannabis can differ substantially; this is why reference entries specify flower, leaf, resin (trichomes) and, where they exist, standardisation markers.